Jubilant Life Sciences receives US FDA approval for dementia drug
The company has received the ANDA approval for memantine hydrochloride tablets, a generic version of Forest Laboratories' Namenda
As on June 30, 2015, Jubilant Life Sciences had a total of 815 filings for formulations of which 389 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 dossier filings in Europe.